Comparing the Efficacy of Remdesivir, Favipiravir, and Casirivimab and Imdevimab on Duration of Hospitalization and ICU Stay of Hospitalized COVID-19 Patients
Life Science Research Communications · 2024
DOI: 10.5530/lsrc.1.1.7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Research Communications, 2024. Verfasst von Sahar Kmal Hegazy und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hegazy, S. K., & Hassan, A. H. (2024). Comparing the Efficacy of Remdesivir, Favipiravir, and Casirivimab and Imdevimab on Duration of Hospitalization and ICU Stay of Hospitalized COVID-19 Patients. Life Science Research Communications. https://doi.org/10.5530/lsrc.1.1.7
Vancouver
Hegazy SK, Hassan AH. Comparing the Efficacy of Remdesivir, Favipiravir, and Casirivimab and Imdevimab on Duration of Hospitalization and ICU Stay of Hospitalized COVID-19 Patients. Life Science Research Communications. 2024. doi:10.5530/lsrc.1.1.7
BibTeX
@article{Hegazy2024,
author = {Hegazy, Sahar Kmal and Hassan, Ahmed Hosny},
title = {Comparing the Efficacy of Remdesivir, Favipiravir, and Casirivimab and Imdevimab on Duration of Hospitalization and ICU Stay of Hospitalized COVID-19 Patients},
journal = {Life Science Research Communications},
year = {2024},
doi = {10.5530/lsrc.1.1.7}
}
EUVIMED